LifeMD Valuation
| LFMD Stock | USD 5.71 0.23 3.87% |
At this time, the firm appears to be undervalued. LifeMD Inc secures a last-minute Real Value of $7.28 per share. The latest price of the firm is $5.71. Our model forecasts the value of LifeMD Inc from analyzing the firm fundamentals such as Profit Margin of (0.09) %, return on equity of -24.63, and Current Valuation of 254.93 M as well as examining its technical indicators and probability of bankruptcy. Key fundamental drivers impacting LifeMD's valuation include:
Price Book 107.7234 | Enterprise Value | Enterprise Value Ebitda (1.30) | Price Sales 1.2465 | Forward PE 27.027 |
Undervalued
Today
Please note that LifeMD's price fluctuation is unstable at this time. Calculation of the real value of LifeMD Inc is based on 3 months time horizon. Increasing LifeMD's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the LifeMD stock is determined by what a typical buyer is willing to pay for full or partial control of LifeMD Inc. Since LifeMD is currently traded on the exchange, buyers and sellers on that exchange determine the market value of LifeMD Stock. However, LifeMD's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 5.71 | Real 7.28 | Target 11.72 | Hype 5.66 |
The real value of LifeMD Stock, also known as its intrinsic value, is the underlying worth of LifeMD Inc Company, which is reflected in its stock price. It is based on LifeMD's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of LifeMD's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of LifeMD Inc helps investors to forecast how LifeMD stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of LifeMD more accurately as focusing exclusively on LifeMD's fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use LifeMD's intrinsic value based on its ongoing forecasts of LifeMD's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against LifeMD's closest peers. If more than one evaluation category is relevant for LifeMD we suggest using both methods to arrive at a better estimate.
LifeMD Cash |
|
LifeMD Valuation Trend
Comparing LifeMD's enterprise value against its market capitalization is a good way to estimate the value of LifeMD Inc uage its performance over time. This information may sometimes be enough for investors to make reasonable market timing decisions.
LifeMD Revenue by Product
LifeMD Total Value Analysis
LifeMD Inc is now expected to have valuation of 254.93 M with market capitalization of 264.83 M, debt of 15.22 T, and cash on hands of 5.84 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the LifeMD fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
254.93 M | 264.83 M | 15.22 T | 5.84 M |
LifeMD Investor Information
About 16.0% of the company outstanding shares are owned by corporate insiders. The company recorded a loss per share of 0.53. LifeMD Inc last dividend was issued on the 14th of October 2020. The entity had 1:5 split on the 14th of October 2020. Based on the measurements of operating efficiency obtained from LifeMD's historical financial statements, LifeMD Inc is doing better financially today then in previous quarter. It has a moderate probability of reporting better financial numbers in April.LifeMD Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. LifeMD has an asset utilization ratio of 2.93E-4 percent. This indicates that the Company is making $3.0E-6 for each dollar of assets. An increasing asset utilization means that LifeMD Inc is more efficient with each dollar of assets it utilizes for everyday operations.LifeMD Ownership Allocation
LifeMD Inc maintains a total of 44.58 Million outstanding shares. 30% of LifeMD outstanding shares are owned by institutional investors. Institutional investors are typically referred to investors that purchase positions in a given stock to benefit from reduced commissions. Consequently, institutional investors are subject to different rules and regulations than regular investors. Please look out for any change in current institutional holding as this could mean something significant has changed at the company or is about to change. Please note that no matter how many assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it.LifeMD Profitability Analysis
The company reported the previous year's revenue of 212.45 M. Net Loss for the year was (18.73 M) with profit before overhead, payroll, taxes, and interest of 188.39 M.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates LifeMD's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in LifeMD and how it compares across the competition.
About LifeMD Valuation
The stock valuation mechanism determines LifeMD's current worth on a weekly basis. Our valuation model uses a comparative analysis of LifeMD. We calculate exposure to LifeMD's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of LifeMD's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 242.4 M | 254.5 M | |
| Pretax Profit Margin | (0.09) | (0.09) | |
| Operating Profit Margin | (0.08) | (0.08) | |
| Net Loss | (0.09) | (0.09) | |
| Gross Profit Margin | 1.14 | 0.63 |
LifeMD Growth Indicators
Investing in growth stocks can be very risky. If the company such as LifeMD does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 41.2 M | |
| Forward Price Earnings | 27.027 |
LifeMD Current Valuation Indicators
Valuation refers to the process of determining the present value of LifeMD Inc and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value LifeMD we look at many different elements of the entity such as LifeMD's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as LifeMD, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use LifeMD's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes LifeMD's worth.Complementary Tools for LifeMD Stock analysis
When running LifeMD's price analysis, check to measure LifeMD's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy LifeMD is operating at the current time. Most of LifeMD's value examination focuses on studying past and present price action to predict the probability of LifeMD's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move LifeMD's price. Additionally, you may evaluate how the addition of LifeMD to your portfolios can decrease your overall portfolio volatility.
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Stocks Directory Find actively traded stocks across global markets | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges |